Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adewale O Adebajo

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
BMJ (Clinical Research Ed.)|June 19, 2023
Multimorbidity: small steps in the right directionAdewale O Adebajo
Clinical Rheumatology|July 19, 2022
Crying out for equity: outcomes of rheumatic diseases confounded by ethnicityShirish Dubey, Adewale O Adebajo
The Journal of Rheumatology|January 12, 2007
Patient's ethnicity and use of therapies in rheumatoid arthritisAdewale O Adebajo, Caroline Mitchell
Current Opinion in Rheumatology|April 26, 2021
Patient educational needs and challenges in psoriatic arthritisAdewale O Adebajo, Richard O Akintayo
Expert Opinion on Pharmacotherapy|August 29, 2019
An evaluation of tofacitinib for the treatment of psoriatic arthritisHunar Abdulrahim, Hisham Sharlala, Adewale O Adebajo
Best Practice & Research. Clinical Rheumatology|February 24, 2026
The challenges in managing Psoriatic Arthritis in resource poor settingsJan René Nkeck, Adewale O Adebajo, Ajesh B Maharaj
BMC Rheumatology|May 30, 2023
Patient and public involvement in rheumatic and musculoskeletal research: an idea whose time has firmly comeAngie Botto-van Bemden, Adewale O Adebajo, Ciarán Martin Fitzpatrick
Rheumatology (Oxford, England)|February 6, 2024
Artificial intelligence and machine learning in rheumatologyShirish Dubey, Antoni Chan, Adewale O Adebajo, et al.
Clinical Rheumatology|February 28, 2026
From voice to value: listening, believing, empowering, and partnering with patients in rheumatologyShirish Dubey, Adewale O Adebajo, Ailsa Bosworth, et al.
Expert Opinion on Pharmacotherapy|April 14, 2015
Apremilast: a PDE4 inhibitor for the treatment of psoriatic arthritisHunar Abdulrahim, Samuel Thistleton, Adewale O Adebajo, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
BMJ (Clinical Research Ed.)|June 19, 2023
Multimorbidity: small steps in the right directionAdewale O Adebajo
Clinical Rheumatology|July 19, 2022
Crying out for equity: outcomes of rheumatic diseases confounded by ethnicityShirish Dubey, Adewale O Adebajo
The Journal of Rheumatology|January 12, 2007
Patient's ethnicity and use of therapies in rheumatoid arthritisAdewale O Adebajo, Caroline Mitchell
Current Opinion in Rheumatology|April 26, 2021
Patient educational needs and challenges in psoriatic arthritisAdewale O Adebajo, Richard O Akintayo
Expert Opinion on Pharmacotherapy|August 29, 2019
An evaluation of tofacitinib for the treatment of psoriatic arthritisHunar Abdulrahim, Hisham Sharlala, Adewale O Adebajo
Best Practice & Research. Clinical Rheumatology|February 24, 2026
The challenges in managing Psoriatic Arthritis in resource poor settingsJan René Nkeck, Adewale O Adebajo, Ajesh B Maharaj
BMC Rheumatology|May 30, 2023
Patient and public involvement in rheumatic and musculoskeletal research: an idea whose time has firmly comeAngie Botto-van Bemden, Adewale O Adebajo, Ciarán Martin Fitzpatrick
Rheumatology (Oxford, England)|February 6, 2024
Artificial intelligence and machine learning in rheumatologyShirish Dubey, Antoni Chan, Adewale O Adebajo, et al.
Clinical Rheumatology|February 28, 2026
From voice to value: listening, believing, empowering, and partnering with patients in rheumatologyShirish Dubey, Adewale O Adebajo, Ailsa Bosworth, et al.
Expert Opinion on Pharmacotherapy|April 14, 2015
Apremilast: a PDE4 inhibitor for the treatment of psoriatic arthritisHunar Abdulrahim, Samuel Thistleton, Adewale O Adebajo, et al.
Pageof 2